Why the study?
Does intravenous succinylcholine increase myoglobinemia and fasciculation in patients receiving statin therapy compared to those not taking statins?
Population
Patients receiving statin medications for hypercholesterolemia
Comparison
Intravenous administration of 1.5 mg/kg… vs Similar patients not taking statin medications
Design
Editorial
Authors
Loading...
Succinylcholine should be avoided in patients receiving statin therapy due to an increased risk of muscle injury, as evidenced by greater myoglobinemia and fasciculation.
Does intravenous succinylcholine increase myoglobinemia and fasciculation in patients receiving statin therapy compared to those not taking statins?
Succinylcholine should be avoided in patients receiving statin therapy due to an increased risk of muscle injury, as evidenced by greater myoglobinemia and fasciculation.
Chingmuh Lee (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: